Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.38 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17769212 | 1.00 | ERN1 (0.38) | ERN1PRKDCLMNAALDH1A1CYP1A2 | |
| SCHEMBL17769216 | 0.79 | HPGD (0.37) | LMNAALDH1A1CYP1A2CYP2C19TSHR | |
| SCHEMBL17769218 | 0.79 | HPGD (0.37) | LMNAALDH1A1CYP1A2CYP2C19TSHR | |
| SCHEMBL29495242 | 0.79 | HPGD (0.37) | LMNAALDH1A1CYP1A2CYP2C19TSHR | |
| SCHEMBL25768537 | 0.71 | ERN1 (0.47) | ERN1PRKDCLMNAALDH1A1CYP1A2 | |
| SCHEMBL14877411 | 0.71 | ERN1 (0.47) | ERN1PRKDCLMNAALDH1A1CYP1A2 | |
| SCHEMBL660309 | 0.71 | ERN1 (0.37) | ERN1PRKDCLMNA | |
| SCHEMBL658069 | 0.70 | CYP2A6 (0.38) | ERN1PRKDCLMNAALDH1A1TSHR | |
| SCHEMBL1145175 | 0.70 | ERN1 (0.47) | ERN1PRKDCLMNAALDH1A1 | |
| SCHEMBL28953827 | 0.69 | PRKDC (0.33) | PRKDCLMNAALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431323-A | Heterobicyclic amides as CD38 inhibitors | 贝林格尔·英格海姆国际有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-114423753-B | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2024-09-17 | — | — | CN | disclosed |
| CN-114423753-A | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2022-04-29 | — | — | CN | disclosed |